Recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB). Final rule |
| |
Authors: | Drug Enforcement Administration Justice |
| |
Affiliation: | Drug Enforcement Administration (DEA), Justice |
| |
Abstract: | DEA is amending its regulations to require additional recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA makes these changes under section 4 of the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000." These additional requirements are necessary to protect against the diversion of GHB for illicit purposes. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|